Population
Patients with cardiovascular and cerebrovascular disorders
Design
Review
Authors
Loading...
Offers synthesis of GP IIb/IIIa patent landscape; leaves open need for updated efficacy trials.
This review summarizes the clinical development and recent patent literature of glycoprotein IIb/IIIa antagonists for cardiovascular and cerebrovascular disorders.
Raddatz et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: